Booster shot study aims to keep teens safe from whooping cough
NCT ID NCT02118961
First seen Jan 11, 2026 · Last updated Jun 14, 2026 · Updated 27 times
Summary
This study tested a booster dose of the DTaP vaccine (BK1301) in 446 adolescents aged 11-12 who had already received the standard childhood series. The goal was to confirm the vaccine boosts immunity against diphtheria, tetanus, and pertussis (whooping cough) safely. Results showed strong immune responses, supporting its use as a booster.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for TETANUS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Inverstigational site
Kumagaya-shi, Saitama, Japan
-
Inverstigational site
Shinjuku-ku, Tokyo, Japan
-
Investigational site
Fukuoka, Fukuoka, Japan
-
Investigational site
Itoshima-shi, Fukuoka, Japan
-
Investigational site
Kasuga-shi, Fukuoka, Japan
-
Investigational site
Hiroshima, Hiroshima, Japan
-
Investigational site
Shizuoka, Shizuoka, Japan
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.